A Study to Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality Disorder
Clinical trial NCT04566601 · COMPLETED
Trial details
- NCT number
- NCT04566601
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-13
- Primary completion
- 2022-12-09
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.